RT Journal Article
SR Electronic
T1 Human mobility and COVID-19 transmission: a systematic review and future directions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.02.21250889
DO 10.1101/2021.02.02.21250889
A1 Zhang, Mengxi
A1 Wang, Siqin
A1 Hu, Tao
A1 Fu, Xiaokang
A1 Wang, Xiaoyue
A1 Hu, Yaxin
A1 Halloran, Briana
A1 Cui, Yunhe
A1 Liu, Haokun
A1 Liu, Zhimin
A1 Bao, Shuming
YR 2021
UL http://medrxiv.org/content/early/2021/02/05/2021.02.02.21250889.abstract
AB Without a widely distributed vaccine, controlling human mobility has been identified and promoted as the primary strategy to mitigate the transmission of COVID-19. Many studies have reported the relationship between human mobility and COVID-19 transmission by utilizing the spatial-temporal information of mobility data from various sources. To better understand the role of human mobility in the pandemic, we conducted a systematic review of articles that measure the relationship between human mobility and COVID-19 in terms of their data sources, statistical models, and key findings. Following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, we selected 47 articles from Web of Science Core Collection up to September 2020. Restricting human mobility reduced the transmission of COVID-19 spatially, although the effectiveness and stringency of policy implementation vary temporally and spatially across different stages of the pandemic. We call for prompt and sustainable measures to control the pandemic. We also recommend researchers 1) to enhance multi-disciplinary collaboration; 2) to adjust the implementation and stringency of mobility-control policies in corresponding to the rapid change of the pandemic; 3) to improve statistical models used in analyzing, simulating, and predicting the transmission of the disease; and 4) to enrich the source of mobility data to ensure data accuracy and suability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the National Science Foundation [1841403; 2027540].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We did not conduct primary data analysis, thus an IRB application is not needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A